S-Gboxin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S-Gboxin, covering 2025-11-19 to 2025-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) [Phase 1]